BRIEF-Salix gets FDA nod for injection techniques for deflux

Mon Nov 18, 2013 7:09am EST

Nov 18 (Reuters) - Salix Pharmaceuticals Ltd : * Announces approval of additional injection techniques for deflux * Says CDRH of FDA has approved deflux premarket approval supplement, single &

double intra-ureteric injection * Source text for Eikon * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.